A published correction fixed record-keeping issues in the POLESTAR trial evaluating early discharge safety and feasibility after ACURATE Neo transcatheter aortic valve implantation. The publisher said the notice does not introduce new clinical findings or change the study’s conclusions. The correction, issued via Clinical Research in Cardiology, addresses procedural and reporting alignment rather than efficacy or safety results. Still, the episode underscores how tightly regulated trial documentation and data integrity are in device studies that inform procedural practice. Given the ongoing interest in shorter hospital stays and streamlined pathways after TAVI, the study’s corrected status may be used by clinicians and developers monitoring implementation timelines.